BULK SUPPLY FOR PROCESSORS, DISTRIBUTORS AND RETAILERS
MORINGA SEEDS BENEFITS:
Purify water
Edible
Rich in amino acids and beta-carotene
Used in perfumes and aromatherapy oils
Moringa also contains calcium, iron, magnesium , slenium.copper and maganese that are essential for healthy hair. Oil from the moringa seed not only rejuvinates the hair follicles and tissues of scalp, it also helps maintain healthier skin.
MORINGA OLEIFERA POWDER:
BULK SUPPLY FOR RETAILERS , PROCESSORS AND DISTRIBUTORS
HEALTH BENEFITS:
Boost Stamina
Controls Diabetes and Blood Pressure
Detoxify and treats Depression
Good for Lactating Mothers
Moringa powder can stay fresh for several months retaining its nutrition and vitamins, minerals, antioxidants, chlorophyll and amino-acids.
Pure and organic, easy to store, soluble and can easily be used as ingredient in wide range of recipes.
Injection molded from medical grade FHR polypropylene our swab is based on the Harvard Wyss Institute Design and meets the specifications of Health Canada. The swab is also registered with the FDA. Our process allows us to produce approximately 60,000 swabs daily and are ideal for testing or to be included in test kits. The price includes gamma sterilization and individually packaged. Website is www.covidtestswab.com Specifications are as follows:
Overall swab length 149.80 mm
Breakpoint distance from tip 75.75 mm
Swab tip length 20 mm
Due to contractual obligations to the federal government, Current suppliers have increased costs and limited production of all point of care tests without notice. We have great news! To shield our customers from excessive price increases as well as provide immediate availability, we have secured multiple FDA EUA rapid antigen test kit options. These tests have similar and/or better accuracy along with individual buffer bottles. We are currently able to provide three options: Clarity-Sienna, Indicaid and Celltrion DiaTrust kits. We work directly with the distributor and can supply by the pallet or case with pricing as low as $6.00 per kit.
Use of this test with all authorized specimen types is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests.
This test is also authorized for use with fingerstick whole blood specimens only at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
The CLIA Waived COVID-19 IgG/IgM Rapid Test Device is an in vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only.
Indication:
Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Emergency use of this test is limited to authorized laboratories.
About Test Device
EUA Authorized
CE Mark
Test does NOT give positive or negative result for COVID-19 virus. This is an antibody test, it only indicates past or recent infection.
Read Results in 15 Minutes
9 Month Expiration from Date of Manufacture
Contents
The CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within the first five days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.
Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., inpatient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
Lateral flow assay
Detect SARS-CoV-2 nucleocapsid protein antigen
Rapid results within 10-15 minutes
Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
For use under the Emergency Use Authorization (EUA) only
For in vitro diagnostic use only
For prescription use only
For use with direct anterior nasal and nasopharyngeal swab specimens
Clinical Performance
93.75% PPAa and 99.32% NPAb when used with nasopharyngeal swab
87.18% PPAa and 100% NPAb when used with anterior nasal swab
The COVID-19 IgG/IgM Rapid Test Device is an in vitro Immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only.
Indication:
Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
About Test Device
Gives Positive or Negative Result for COVID-19 IgM/IgG antibodies
Read Results in 15 Minutes
Contents of each box
STANDARD M nCoV Real-Time Detection kit is used for rapid identification and detection of novel coronavirus (2019-nCoV) nucleic acids in human nasopharyngeal swabs and throat swab samples.
- One tube reaction for identification and detection of 2019-nCoV
- One-step Real-Time RT-PCR
- Provide all reagents required for PCR
- Designed according to WHO interim guidance for laboratory testing for 2019 novel coronavirus (2019-nCoV) in humans"
- nCoV primers/probes ORF1ab (RdRp) gene, E gene
Provide Internal controls
Kindly check ghope-ppe.com. All information is for a consumer. If you want to buy a bulk, please contact us.
The CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare providers.
Highest accuracy
Fast result interpretation
Cost effective
Made with best choices of materials
Type: immunoassay system
Brand name: ntbio/oem/private label
Place of origin: british columbia, canada
Size: 60mm x 300mm
Accuracy: 99.9%
Sensitivity: 20 miu/ml
Specimen: urine .
We have just achieved a major breakthrough in the development of dengue igg/igm antibody early test. Our new product is capable to detect the presence of dengue igm antibody in human serum within 3-5 days since primary infection (tested and verified with reference standard blood sample from usa cdc), while similar products currently found on the market can only detect it after at least 10-15 days. The significance of this achievement is that the new dengue igg/igm antibody early test now can diagnose dengue infection at a very early stage, which previously could only be done with a dengue ns1 antigen test.
Type: immunoassay system
Brand name: ntbio/oem/private label
Place of origin: british columbia, canada
Size: 60mm x 300mm
Sensitivity: 95.3%
Specificity: 95.0%
Specimen: whole blood/serum/plasma .
Highest accuracy
Fast result interpretation
Cost effective
Made with best choices of materials
Type: immunoassay system
Brand name: ntbio/oem/private label
Place of origin: british columbia, canada
Size: 60mm x 300mm
Sensitivity: 94.3%
Specificity: >98.9%
Specimen: whole blood/serum/plasma .
Highest accuracy
Fast result interpretation
Cost effective
Made with best choices of materials
Type: immunoassay system
Brand name: ntbio/oem/private label
Place of origin: british columbia, canada
Size: 60mm x 300mm
Accuracy: 99.9%
Sensitivity: 20 miu/ml
Specimen: urine .
